Skip to main content

ORIGINAL RESEARCH article

Front. Med.
Sec. Hepatobiliary Diseases
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1514327

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: Insights from the MINIC Database

Provisionally accepted
Liping Zhan Liping Zhan 1Du Shenshen Du Shenshen 2Yuping Yang Yuping Yang 1Biao Nie Biao Nie 1Yuan Tian Yuan Tian 3Yujie Huang Yujie Huang 1Ruyin Ye Ruyin Ye 1Yanqi Kou Yanqi Kou 4Zhe Huang Zhe Huang 1Botao Luo Botao Luo 3Lei Ge Lei Ge 1Shicai Ye Shicai Ye 1*
  • 1 Affiliated Hospital of Guangdong Medical College Hospital, Zhanjiang, Guangdong Province, China
  • 2 Huanghe Sanmenxia Hospital, Sanmenxia, Henan Province, China
  • 3 Guangdong Medical University, Zhanjiang, China
  • 4 The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan Province, China

The final, formatted version of the article will be published soon.

    Objectives: This study investigates serum markers for short-term prognosis in hepatic encephalopathy patients.Background: Patients with hepatic encephalopathy face elevated mortality rates and bleak prognoses. However, effective prognostic models or indicators are lacking. This study aims to explore serum markers for predicting short-term prognosis in these patients.We conducted a retrospective analysis of 552 patients with hepatic encephalopathy, categorizing 429 individuals meeting exclusion criteria into normal and high activated partial thromboplastin time (APTT) groups. We assessed 12-day and 25-day survival rates using Kaplan-Meier analysis and Cox regression models to examine associations between groups and outcomes.Results: Upon comparing baseline characteristics, the high APTT group exhibited significant disparities in acute kidney injury, sepsis, coagulation disorders, and ascites (p < 0.05). In the multivariate COX regression model, the hazard ratios (HRs; 95% confidence interval [CI]) of 12-and 25-day mortality were 1.012 (1.001,1.022, p = 0.033) and 1.010 (1.002,1.018, p = 0.013), respectively. We discovered that APTT demonstrated an independent association with prognosis. Our findings revealed that the ability of APTT to predict short-term prognosis surpasses that of the traditional MELD model. Regarding 12-and 25-day survival, Kaplan-Meier survival curves from these groups demonstrated a lower survival probability for patients in the high APTT group than the normal group (log-rank p < 0.05). The results of subgroup analysis and interaction analysis indicate that APTT is not influenced by other confounding factors.A prolonged APTT suggests a poorer short-term prognosis in patients with hepatic encephalopathy. Keyword:hepatic encephalopathy,APTT,prognosis.

    Keywords: Hepatic Encephalopathy, APTT activated partial thromboplastin time, prognosis, Risk facors, database

    Received: 20 Oct 2024; Accepted: 23 Jan 2025.

    Copyright: © 2025 Zhan, Shenshen, Yang, Nie, Tian, Huang, Ye, Kou, Huang, Luo, Ge and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Shicai Ye, Affiliated Hospital of Guangdong Medical College Hospital, Zhanjiang, Guangdong Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.